Results 211 to 220 of about 389,122 (252)
Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial. [PDF]
Güller U +16 more
europepmc +1 more source
Baseline systolic blood pressure and efficacy of dual antiplatelet in acute ischaemic stroke. [PDF]
Cui Y, Wang Y, Chen HS.
europepmc +1 more source
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial. [PDF]
Wu S +16 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Therapeutische Umschau, 1999
Acetylsalicylsäure (Aspirin) war das erste synthetisch hergestellte Medikament, das vor 100 Jahren erstmals produziert wurde. Während andere Medikamente alle wieder verschwanden, hat Aspirin einen einmaligen Siegeszug angetreten. Initial wurde es wegen seiner analgetischen, antipyretischen und antiphlogistischen Wirkung gebraucht.
M K DAVIES, A HOLLMAN
openaire +3 more sources
Acetylsalicylsäure (Aspirin) war das erste synthetisch hergestellte Medikament, das vor 100 Jahren erstmals produziert wurde. Während andere Medikamente alle wieder verschwanden, hat Aspirin einen einmaligen Siegeszug angetreten. Initial wurde es wegen seiner analgetischen, antipyretischen und antiphlogistischen Wirkung gebraucht.
M K DAVIES, A HOLLMAN
openaire +3 more sources
On the Polymorphism of Aspirin
Angewandte Chemie International Edition, 2007More headaches with aspirin: No new polymorph? Reduction and re-indexing of X-ray data collected on a crystal of the well-known form I of aspirin in a unit cell recently reported for the new form II results in a data set from which this so-called new form can be obtained and even refined isotropically! Form II, if it exists, needs to be identified with
Bond, Andrew +2 more
openaire +3 more sources
The Lancet, 2006
Aspirin resistance is the inability of aspirin to reduce platelet production of thromboxane A2 and thereby platelet activation and aggregation. Increasing degrees of aspirin resistance may correlate independently with increasing risk of cardiovascular events.
Hankey Graeme J, Eikelboom John W
openaire +7 more sources
Aspirin resistance is the inability of aspirin to reduce platelet production of thromboxane A2 and thereby platelet activation and aggregation. Increasing degrees of aspirin resistance may correlate independently with increasing risk of cardiovascular events.
Hankey Graeme J, Eikelboom John W
openaire +7 more sources

